Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Agea | 0.98 | 0.95–1.01 | 0.140 |  |  |  |
FIGO stage | 2.02 | 1.36–3.00 | < 0.001 |  |  |  |
Tumor sizea | 1.43 | 1.14–1.08 | 0.002 | 1.37 | 1.06–1.77 | 0.015 |
Pelvic lymph node | 1.89 | 0.90–3.96 | 0.094 |  |  |  |
Para-aortic lymph node | 4.21 | 1.89–9.40 | < 0.001 | 3.75 | 1.39–10.15 | 0.009 |
SCC antigena | 1.01 | 1.00–1.01 | 0.122 |  |  |  |
pSUVmaxa | 1.04 | 0.99–1.08 | 0.086 |  |  |  |
Nodal SUVmaxa | 1.07 | 1.04–1.11 | < 0.001 | 1.05 | 1.01–1.09 | 0.020 |
HPV negative | 2.37 | 1.01–5.55 | 0.047 | 3.68 | 1.44–9.41 | 0.007 |